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ARTICLE
Methylation deficiency disrupts biological rhythms
from bacteria to humans
Jean-Michel Fustin 1,16,18✉, Shiqi Ye1,18, Christin Rakers 2, Kensuke Kaneko3, Kazuki Fukumoto1,
Mayu Yamano1, Marijke Versteven4, Ellen Grünewald5, Samantha J. Cargill5, T. Katherine Tamai 6, Yao Xu7,
Maria Luísa Jabbur7, Rika Kojima8, Melisa L. Lamberti9, Kumiko Yoshioka-Kobayashi10, David Whitmore 11,
Stephanie Tammam12, P. Lynne Howell 12,13, Ryoichiro Kageyama10, Takuya Matsuo14, Ralf Stanewsky 4,
Diego A. Golombek9, Carl Hirschie Johnson7, Hideaki Kakeya 3, Gerben van Ooijen 5 &
Hitoshi Okamura15,17✉
The methyl cycle is a universal metabolic pathway providing methyl groups for the methy-
lation of nuclei acids and proteins, regulating all aspects of cellular physiology. We have
previously shown that methyl cycle inhibition in mammals strongly affects circadian rhythms.
Since the methyl cycle and circadian clocks have evolved early during evolution and operate
in organisms across the tree of life, we sought to determine whether the link between the two
is also conserved. Here, we show that methyl cycle inhibition affects biological rhythms in
species ranging from unicellular algae to humans, separated by more than 1 billion years of
evolution. In contrast, the cyanobacterial clock is resistant to methyl cycle inhibition, although
we demonstrate that methylations themselves regulate circadian rhythms in this organism.
Mammalian cells with a rewired bacteria-like methyl cycle are protected, like cyanobacteria,
from methyl cycle inhibition, providing interesting new possibilities for the treatment of
methylation deficiencies.
https://doi.org/10.1038/s42003-020-0942-0 OPEN
1 Graduate School of Pharmaceutical Sciences, Laboratory of Molecular Metabology, Kyoto University, Kyoto, Japan. 2 Graduate School of Pharmaceutical
Sciences, Kyoto University, Kyoto, Japan. 3 Graduate School of Pharmaceutical Sciences, Department of System Chemotherapy and Molecular Sciences,
Kyoto University, Kyoto, Japan. 4 Institute of Neuro- and Behavioral Biology, University of Münster, Münster, Germany. 5 School of Biological Sciences,
University of Edinburgh, Edinburgh, UK. 6 Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA.
7Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA. 8 Karolinska Institute, Stockholm, Sweden. 9 Department of Science and
Technology, National University of Quilmes/CONICET, Buenos Aires, Argentina. 10 Institute for Frontier Life and Medical Sciences, Kyoto University,
Kyoto, Japan. 11 Centre for Cell and Molecular Dynamics, Department of Cell and Developmental Biology, University College London, London, UK.
12Molecular Medicine, Peter Gilgan Centre for Research and Learning (PGCRL), The Hospital for Sick Children, Toronto, ON, Canada. 13 Department of
Biochemistry, University of Toronto, Toronto, ON, Canada. 14 Center for Gene Research, Nagoya University, Nagoya, Japan. 15 Graduate School of
Pharmaceutical Sciences, Laboratory of Molecular Brain Science, Kyoto University, Kyoto, Japan. 16Present address: The University of Manchester, Faculty of
Biology, Medicine and Health, Oxford Road, Manchester M13 9PL, UK. 17Present address: Kyoto University, Graduate School of Medicine, Department of
Neuroscience, Division of Physiology and Neurobiology, Yoshida-Konoe-cho, Oxford Road, Sakyo-ku, Kyoto 606-8501, Japan. 18These authors contributed
equally: Jean-Michel Fustin, Shiqi Ye. ✉email: jean-michel.fustin@manchester.ac.uk; okamura.hitoshi.4u@kyoto-u.ac.jp
COMMUNICATIONS BIOLOGY |           (2020) 3:211 | https://doi.org/10.1038/s42003-020-0942-0 | www.nature.com/commsbio 1
12
34
56
78
9
0
()
:,;
Methylation reactions start with the metabolization ofmethionine into S-adenosylmethionine, or SAM: theuniversal methyl donor co-substrate in the trans-
methylation of nucleic acids, proteins, carbohydrates, phospho-
lipids and small molecules. During the methylation process, SAM
is converted into adenosylhomocysteine (SAH) that is rapidly
hydrolyzed into homocysteine (Hcy) and adenosine by the
enzyme adenosylhomocysteinase (AHCY) to prevent competitive
inhibition of methyltransferase enzymes by SAH. The ratio SAM/
SAH is critical and is a measure of the methylation potential: the
tendency to methylate biomolecules1–3. Methylation deficiencies,
either from poor diet or genetic polymorphisms, contribute to the
etiology of many pathologies: cancer, atherosclerosis, birth
defects, aging, diabetes and pancreatic toxicity, hepatotoxicity and
neurological disturbances4.
An endogenous circadian clock evolved to anticipate the daily
cycles of light and darkness has been found in many organisms,
from cyanobacteria to humans. Transcription-translation feed-
back loops of “clock genes” directly or indirectly regulating their
own transcription underlie many functions of the clock, and drive
oscillations of output genes controlling physiology and behavior.
Some molecular components of the clock are remarkably con-
served in Metazoa, notably the genes Clock and Period, coding for
transcription factors, with Clock activating the transcription of
Per and Per inhibiting its own transcription5. In 2013, we
reported that inhibition of the methyl cycle by AHCY inhibitors
strongly affected the circadian clock in mouse and human cells6.
We now show that the link between methylation and the circa-
dian clock we uncovered in mammals has been conserved during
more than 2.5 billion years of evolution, and that circadian
rhythm perturbations can be used as a quantitative gauge for the
physiological consequences of methylation deficiency.
Bacterial species exist that lack AHCY but instead express an
ancient SAH nucleosidase that hydrolyses SAH into S-
ribosylhomocysteine and adenine7,8. Surprisingly, partial rewir-
ing of the mammalian methyl cycle by ectopically expressing the
E. coli SAH nucleosidase completely protected the methyl cycle
from AHCY inhibition, and allowed normal circadian rhythms,
even in the presence of a saturating concentration of inhibitor.
These observations demonstrate the importance of methyl
metabolism in the regulation of biological rhythms from cyano-
bacteria to humans and suggest a therapeutic application of
methyl cycle reprogramming to alleviate the detrimental impact
of methylation deficiencies.
Results
AHCY is a highly conserved enzyme in the methyl cycle.
Methylation deficiency can be induced by carbocyclic adenosine
analogs identified as AHCY inhibitors more than 30 years ago,
such as 3-Deazaneplanocin A (DZnep)9–11. This pharmacological
inhibition mimics the pathological symptoms caused by AHCY
deficiency12, such as high plasma methionine, SAM and SAH; all
indicators of methyl cycle aberrations. AHCY catalyzes the clea-
vage of SAH to adenosine and L-homocysteine, and DZnep
inhibits this reaction by occupying the adenosine binding site of
AHCY. The crystal structures of human13, mouse14 and yellow
lupin (Lupinus luteus)15 AHCY complexed with adenosine or
analogs have been described, and insights into its catalytic activity
have been obtained16–19. AHCY is one of the most evolutionarily
conserved proteins20, but experimentally determined structures of
AHCY complexed with DZnep remain to be described for most
organisms. A full-length multiple sequence alignment (Supple-
mentary Fig. 1) and homology modeling of AHCY from humans
to cyanobacteria (Fig. 1a and Supplementary Movie 1) revealed
high conservation of sequence and predicted tertiary structure.
Amino acids contributing to the DZnep binding site showed at
least 88% identity between all eukaryotic AHCY sequences, and
78% between human and bacterial sequences, indicating that the
DZnep binding site is virtually identical across a wide range of
organisms (Fig. 1b, c and Supplementary Fig. 2). Moreover,
amino acids that were reported as crucial for the activity of rat
AHCY (His55, Asp130, Glu155, Lys186, Asp190, and Asn19119)
are universal (Supplementary Fig. 1). In line with the above,
molecular docking simulations of AHCY with adenosine or
DZnep revealed comparable ligand binding conformations and
estimated binding free energies for all organisms (Fig. 1d and
Supplementary Fig. 2).
DZnep is sometimes erroneously considered to be a histone
methyltransferase EZH2 inhibitor, because of the misinterpreta-
tion of a report showing that it inhibits histone methylation sites
targeted by EZH2 in cancer cells21. More recent reports showed
that DZnep widely inhibits histone methylation, in line with its
inhibitory effect via AHCY22,23. Together these observations
strongly support the use of DZnep as a valid approach to disrupt
the methyl cycle across taxa, as we next demonstrate.
Methylation deficiency disrupts the metazoan circadian clock.
To test the effects of DZnep on the mammalian clock, we exposed
a human osteosarcoma cell line (U-2 OS) and PER2::LUC mouse
embryonic fibroblasts (MEFs), expressing bioluminescent clock
reporters24,25, to DZnep concentrations. In human (Fig. 2a, b)
and mouse (Fig. 2c, d) cells, DZnep potently and dose-
dependently increased the period of circadian oscillations,
visualized by bioluminescent rhythms of Bmal1 or Per2 expres-
sion, respectively.
We next tested DZnep on the zebrafish embryonic PAC2 cell
line expressing a luminescent reporter of the Per1b gene, a non-
mammalian cell type commonly used for circadian studies, and
revealed, as observed in mammalian cells, a clear effect of the
drug on the circadian period (Fig. 2e, f). An effect on the
entrainment to the light/dark cycles (see methods) was also
observed: The Per1b gene normally peaks at dawn but was
severely blunted and delayed in DZnep-treated cells.
To test the effects of methylation deficiency on circadian
rhythms in invertebrates, we exposed Drosophila melanogaster
haltere cultures from transgenic luciferase reporter ptim TIM-
LUC flies to DZnep. As observed in vertebrates, DZnep caused
dose-dependent period lengthening (Fig. 2g, h). In addition, an
effect of 100 μM DZnep on the luminescent rhythms reporting
the expression of the sur-5 gene was also observed in freely
moving C. elegans (Supplementary Fig. 3), a relatively new model
in circadian biology26.
Methylation deficiency also disrupts the somite segmentation
clock. While the metazoan circadian clock is an oscillator with a
period near 24 h, the somite segmentation clock in mammalian
embryos cycles much faster and orchestrates the appearance of
new segments or “somites” from the paraxial mesoderm (Sup-
plementary Fig. 4a). The underlying molecular oscillator is cen-
tered on the transcription factor Hairy & Enhancer Of Split 7
(Hes7), the expression of which oscillates with a period close to 2
h in mouse27. Like circadian clock genes, Hes7 oscillatory
expression can be monitored in real-time from transgenic
embryos expressing highly destabilized luciferase under the
control of the Hes7 promoter. Testing increasing concentrations
of DZnep on these transgenic embryos revealed clear similarity to
the effects of DZnep on circadian clock markers, resulting in the
lengthening of the somite segmentation clock period (Supple-
mentary Fig. 4b–d, Supplementary Movie 2). Together, these data
demonstrate the importance of the methyl cycle in the regulation
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Fig. 1 Adenosylhomocysteinase is a highly conserved protein. a Structural superposition of AHCY from the 9 organisms investigated here, using human
(1LI4), mouse (5AXA) or lupin (3OND) crystal structures as templates. The blue loop is specific to plants and green algae; DZnep is shown in yellow,
NAD+ in black. See also Supplementary Movie 1. b Docking simulation of human AHCY with DZnep, based on the 1LI4 crystal structure of human AHCY
complexed with Neplanocin A, an analog of DZnep. The amino acids involved in DZnep binding are indicated with their position. See Supplementary Fig. 2
for docking simulations of DZnep to AHCY from other organisms. Red and green arrows are hydrogen bonds, yellow spheres are hydrophobic effects. The
estimated free energy of binding for depicted DZnep docking conformation was −9.87 kcal/mol. c Discontinuous alignment of amino acids contributing to
the binding of DZnep, using the human sequence as a reference and with sequence identities shown on the right. When amino acids are identical to human,
a dot is shown in the alignment. The sequence logo on top is a graphical representation of the conservation of amino acids, with the consensus symbols
below (* = fully conserved residue, : = conservation of strongly similar properties, . = conservation of weakly similar properties). The positions of selected
conserved amino acids are given for the human sequence on top of the alignment. d Molecular docking simulations of AHCY with adenosine and DZnep
showing comparable binding free energies in all organisms. Colors represent full sequence identities, relative to human.
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Fig. 2 Circadian rhythms are a quantitative gauge for methylation deficiency in Metazoa. a Mean luminescence ± SEM of human Bmal1-luc U-2 OS
cells25 treated with increasing concentrations of DZnep; b shows mean ± SEM of period, n= 3 dishes. c Mean luminescence ± SEM of PER2::LUC MEF24
treated with DZnep, n= 3 dishes; mean ± SEM of period shown in d. e Mean luminescence ± SEM of Per1b-luciferase PAC-2 zebrafish cells treated with
DZnep, n= 4 dishes; mean ± SEM of period shown in f; note the initial 96 h of data performed under light/dark cycles. g Mean luminescence ± SEM of
ptim-TIM-LUC Drosophila halteres treated with DZnep, n= 8 independent halteres, with only the upper segment of the error bars shown for clarity; mean ±
SEM of period shown in h. All bar graphs analyzed by One-Way ANOVA followed by Bonferroni’s test; all indicated comparisons (a vs. b vs. c vs. d vs. e),
at least p < 0.05.
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of transcriptional programs orchestrating biological rhythms in
Metazoa.
Methylation deficiency disrupts the clock in plants and algae.
The most commonly used model organism to study circadian
rhythms in land plants is Arabidopsis thaliana. We thus tested the
effects of DZnep on luminescent rhythms reporting the expres-
sion of the plant evening gene TOC1 in protoplasts and extended
our investigations to aquatic unicellular green algae. Ostreococcus
tauri and Chlamydomonas reinhardtii represent two different
classes of unicellular green algae that have successfully been used
in circadian studies and constitute great models to investigate
cell-autonomous metabolic processes28–30. We tested increasing
concentration of DZnep on Arabidopsis (Fig. 3a, b), Ostreococcus
tauri (Fig. 3c, d) and Chlamydomonas reinhardtii (Fig. 3f, g), and
observed an increase in period length almost identical to the
results obtained in vertebrates. A plant- and green algae-specific
domain has been previously described in AHCY31, from amino
acids 151 to 191 (Fig. 1 and Supplementary Fig. 1). Despite this
insertion, however, the domains for SAH and NAD+ binding are
remarkably conserved. We already showed that DZnep analogs
increase SAH in mammalian cells6, but to confirm that DZnep
does increase SAH also in the green plant clade, we quantified
SAM and SAH in DZnep-treated algae and revealed a dose-
dependent increase in SAH and a decrease in methylation
potential (Fig. 3e, h and Supplementary Fig. 5). In conclusion, the
effects of DZnep treatment on transcriptional rhythms are also
conserved in the plant kingdom. These results are especially
meaningful given unicellular algae and humans are separated by
more than 1 billion years of evolution32.
The methyl cycle in cyanobacteria is less sensitive to AHCY
inhibition. The circadian oscillator in cyanobacteria is composed of
three proteins. Kai-A, -B and -C form a complex that regulates two
key activities of KaiC: ATPase and autophosphorylation activity
that result in an autonomous and self-sustained phosphorylation-
based oscillator ticking with a period close to 24-h. In a cellular
context, this non-transcriptional oscillator controls transcriptional
outputs that in turn add robustness to the biochemical oscillator via
transcription-translation feedback loops33. Despite these pro-
nounced differences in clock architecture, the circadian period in
cyanobacteria lengthened in response to low concentrations of
DZnep (Fig. 4a, b), but with a much lower magnitude compared to
that in the eukaryotes tested here.
Inhibition of methylations by DZnep depends on the unique
activity of AHCY to directly hydrolyze SAH into Hcy and
adenosine. In prokaryotes, the enzyme 5’-methylthioadenosine/S-
adenosylhomocysteine nucleosidase (MTAN) has a SAH nucleo-
sidase activity that cleaves SAH to adenine and S-
ribosylhomocysteine34. This pathway for AHCY catabolism,
acting as a buffer against SAH accumulation, could explain the
weaker response to DZnep compared to eukaryotes. Indeed,
MTANs have been identified in some Synechococcus strains, such
as PCC7336 and MED-G6935. The lack of a strong response to
DZnep may be due either to the presence of MTAN in S.
elongatus, to DZnep being unable to bind to AHCY (this may be
supported by the lowest sequence identity of AHCY in S.
elongatus shown in Fig. 1) or having low bioavailability, or to the
lack of methylation-dependent regulation of the cyanobacterial
clock. Surprisingly, higher concentrations of the drug caused no
significant effects on the period (Fig. 4b). Therefore, to
independently verify the importance of methylations for
cyanobacterial clock, we used the global methylation inhibitor
sinefungin. This is a natural analog of SAM that directly binds to
and inhibits methyltransferases36; sinefungin was previously used
in cyanobacteria to elicit methylation-dependent morphological
changes37. Sinefungin was more potent than DZnep, causing
a dose-dependent period lengthening of a much greater
magnitude (Fig. 4c, d). These data reveal an unexpected role for
methylation even in the cyanobacterial circadian clock, but the
methyl cycle in these cells appeared more resilient to DZnep-
induced deficiency, maybe because of an alternative pathway for
SAH catabolism that eukaryotes lack (Fig. 4e).
Bacterial SAH nucleosidase rescues mammalian cells from
AHCY inhibition. AHCY mutations (R49C, D86G, Y143C,
W112X and A89V) in humans lead to greatly elevated levels of S-
adenosylhomocysteine (>100-fold), causing early developmental
stagnation and severe pathophysiology12,38,39. If the methyl cycle
in these patients could be rewired to prevent S-
adenosylhomocysteine build-up, it would protect them from
AHCY deficiency. To test this potentially transformative
hypothesis, we ectopically expressed the wild-type (WT) or the
inactive D197A mutant MTAN from E. coli8 in mouse and
human cells. In itself, expression of the MTAN variants, which
was confirmed in mouse and human cells by immunoblotting, did
not significantly change circadian parameters (Supplementary
Fig. 6a, b). Cells transfected with either vectors grew well and did
not display any abnormalities, in line with S-ribosylhomocysteine
being a meaningless metabolite in mammalian cells. Strikingly, a
complete protection from the effects of DZnep was seen in
human cells expressing WT MTAN, even at the saturating con-
centrations of 10 and 100 μM (Fig. 5a). D197A MTAN did not
provide protection, indicating the specificity of the effect (Fig. 5b).
Identical results were observed in mouse cells (Fig. 5c, d).
Quantification of period in human and mouse cells clearly
revealed this protective effect of WT MTAN (Fig. 5e, f). Mortality
and/or cell growth inhibition was observed at high DZnep con-
centrations on cells actively growing, but WT MTAN protected
the cells against this effect whereas D197A MTAN did not
(Supplementary Fig. 6c–f). Quantification of SAM and SAH
confirmed the DZnep-dependent increase in SAH and resultant
collapse of the methylation potential in cells transfected with
mutant, but not wild-type MTAN (Fig. 5g, Supplementary Fig. 6g,
h). Interestingly, in vehicle-treated cells the expression of the
wild-type MTAN was sufficient to increase the methylation
potential compared to cells expressing the mutant enzyme
(Supplementary Fig. 6g, h).
Finally, we sought to determine the effects of DZnep on global
lysine and arginine methylation, on RNA and mRNA N6-
methyladenosine (m6A), and on DNA 5-methylcytosine (m5C),
as well as the rescue of their potential inhibition by MTAN in
mouse cells. In all cases, PER2::LUC MEFs were treated with
DZnep 0, 5 or 10 μM (to obtain near-maximum period
lengthening) for 48-hours.
Immunoblotting using an antibody against mono- and di-
methylated lysine showed that a few proteins had lower
methylated levels under DZnep treatment, but only in cells
transfected with the mutant inactive MTAN (Fig. 5h). Probing
mono- and di-methylated arginine in the same cells
showed somewhat less pronounced methylation inhibition,
which was also rescued by WT MTAN (Supplementary Fig. 6i).
We also checked the global levels of the specific methyl marks
Histone 4 Arginine 3 symmetric demethylation (transcriptional
repression) and Histone H3 Lysine 4 trimethylation (transcrip-
tional activation) but little inhibition was seen (Supplementary
Fig. 6i).
N6-methyladenosine did not significantly fluctuate between
treatments when measured from total RNA samples, composed
mainly (>90%) of 18S and 28S rRNA, each macromolecule
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containing only one single m6A site (Supplementary Fig. 6j).
When quantified from mRNA, however, a decrease in m6A
was detected under DZnep treatment, but only in cells
transfected by the mutant inactive MTAN (Fig. 5i, j, k). In
contrast, DNA m5C was not significantly affected (Supplemen-
tary Fig. 6k).
It is possible that a longer treatment with DZnep may have
affected more stable methylations such as m6A in rRNA and
m5C in DNA or caused a more widespread inhibition of histone
methylation, but since the period lengthening effects of DZnep
are observable by 24 h we speculate these methylations may not
contribute to the period lengthening. Promoter-specific DNA or
Fig. 3 Biological rhythms are a quantitative gauge for methylation deficiency in plants and algae. a Mean luminescence ± SEM of Arabidopsis thaliana
CCA1pro:LUC protoplasts treated with different concentration of DZnep, n= 8 wells per treatment. For comparison between different runs, traces were
aligned in relation to the first peak; b shows mean ± SEM of period, n= 8 wells. c Mean luminescence ± SEM of CCA1-LUC Ostreococcus tauri cells, n= 7
wells; d shows mean ± SEM of period, n= 7 wells. No significance was observed between 10, 20 and 30 μM, but the significance compared to 0 μM
became stronger, i.e., p < 0.05, p < 0.001, p < 0.0001, respectively, indicating dose-dependent effects. e Mean SAH concentration ± SEM in O. tauri treated
with the indicated concentrations of DZnep, n= 3 wells. f Mean luminescence ± SEM of tufA-lucCP Chlamydomonas reinhardtii CBR cells treated with
DZnep, n= 5 wells per treatment; g shows mean ± SEM of period, n= 5 wells. h Mean SAH concentration ± SEM in C. reinhardtii treated with the indicated
concentrations of DZnep, n= 4 wells. All bar graphs analyzed by One-Way ANOVA (all p < 0.0001) followed by Bonferroni’s test; all indicated
comparisons (a vs. b vs. c vs. d) at least p < 0.05. See also Supplementary Fig. 5.
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Fig. 4 Cyanobacteria are less sensitive to AHCY inhibition. aMean luminescence ± SEM of Synechococcus PCC 7942 kaiBCp::luxAB knock-in strain treated
with different concentrations of DZnep, n= 3 colonies, with only the upper section of the error bars and higher DZnep concentrations shown on a different
graph for clarity; b shows mean period ± SEM, n= 3 colonies. cMean luminescence ± SEM of Synechococcus PCC 7942 kaiBCp::luxAB treated with different
Sinefungin concentrations as indicated over the graphs; d shows mean period ± SEM, n= 3 colonies. e Organization of the methyl cycle, with the two-steps
SAH conversion to homocysteine in bacteria, starting with MTAN. One arrow represents one enzyme, except for methyltransferases that all use SAM as a
co-substrate to methylate different targets, generating SAH in the process. The enzyme AHCY, mediating SAH hydrolysis and inhibited by DZnep, is
indicated on the picture. All bar graphs analyzed by One-Way ANOVA followed by Bonferroni’s test; all indicated comparisons (a vs. b vs. c vs. d) at least
p < 0.05.
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-020-0942-0 ARTICLE
COMMUNICATIONS BIOLOGY |           (2020) 3:211 | https://doi.org/10.1038/s42003-020-0942-0 | www.nature.com/commsbio 7
histone methylation, for example in the promoter of clock genes,
which would not be detectable when global methylation is
quantified, may also be inhibited by DZnep.
In conclusion, here we have revealed the evolutionarily
conserved link between methyl metabolism and biological clocks.
Moreover, we have demonstrated in mammalian cells that the
period lengthening effects of DZnep exclusively depends on the
inhibition of AHCY and the increase in SAH, mainly leading to
protein and mRNA m6A methylation inhibition. We propose
that the partial rewiring of the mammalian methyl cycle,
protecting proteins and nucleic acids from the consequences of
methyl cycle inhibition, might present a previously unreported
strategy to treat methylation deficiencies, such as homocysteine-
mia or the autosomal recessive AHCY deficiency12,38–41.
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Discussion
Solar ultraviolet radiation played a critical role in prebiotic
chemistry, but the energy of UV photons can also degrade bio-
logically important molecules, preventing abiogenesis. Once
autocatalytic pseudo-life forms evolved with more complex
chemistry, avoidance mechanisms may have provided increased
fitness in such an environment. The origin of the circadian clock
on the early Earth is likely to have been a simple sensing of
molecules present in the milieu, increasing or decreasing under
UV exposure and triggering an appropriate response. Methyl
cycle metabolites are thought to have been present in the pre-
biotic world, since methionine can be created by a spark discharge
and is proposed to be an intermediate in the prebiotic synthesis of
Hcy, which was also found among organic molecules synthesized
in the 1972 Miller experiment42. In addition, formaldehyde, an
abundant prebiotic molecule increasing during the day under the
action of UV on carbon monoxide and water vapor43 could have
affected the chemistry of early life-forms by methylation44 and
may have worked like a chemical marker of daylight. A conserved
link between methyl transfer and the circadian clock may have
arisen from such a scenario.
In mammalian cells we previously reported that methyl cycle
inhibition decreases the methylation of internal adenosines in
mRNA (m6A), as well as that of histones6. While specific mRNA
m6A inhibition was sufficient to elicit period elongation, histone
methylation likely contributed to the period elongation obtained
by DZnep, as well as that of other methylation sites in mRNA,
rRNA and tRNA. Due to the considerable heterogeneity in
mechanisms regulating gene expression and function in organ-
isms tested here, identifying a single mechanism explaining per-
iod elongation in all taxa would be a difficult undertaking and is
beyond the scope of the present work. Since the oldest methyl-
transferases are RNA methyltransferases45, it is tempting to
propose that inhibition of RNA methylation may at least partially
contribute to the period lengthening in all species.
That mammalian cells expressing E. coli MTAN are completely
protected from the period-lengthening effects of DZnep demon-
strates that these effects are solely dependent upon methyl cycle
inhibition and SAH accumulation. Moreover, we have shown in
mouse cells that the functional consequences of methyl cycle
inhibition, i.e., a decrease in the methylation of proteins and
mRNA, is also rescued by WT MTAN. This confirms that
MTAN, despite removing SAH from the cycle in a way that does
not normally occur in mammalian cells, allows the methyl cycle
to turn and drive cellular methylations when AHCY does not
function. MTAN hydrolyses SAH to S-ribosylhomocysteine and
adenine, not to Hcy and adenosine as AHCY does. Since Hcy is
needed for the regeneration of methionine in the methyl cycle,
how could the methyl cycle still maintain cellular methylations
active without Hcy? It is likely that, with the abundance of free
methionine in the cell, the synthesis of SAM and downstream
methylations can continue unimpaired even when Hcy is low.
Hcy is however also used for the synthesis of glutathione (GSH)
via cystathionine and cysteine, a metabolic route called the
transsulfuration pathway (Hcy → cystathionine → cysteine →
GSH), which could potentially have been inhibited by MTAN
expression and DZnep. To investigate potential disruption of this
pathway caused by either DZnep or MTAN, we quantified these
metabolites from cell extracts used in Fig. 5g. As expected,
expression of WT MTAN caused a decrease in Hcy compared to
cells expressing D197A (Supplementary Fig. 7). Overall, however,
the transsulfuration pathway appeared more active in cells
expressing WT MTAN, especially given the higher concentrations
of cysteine and GSH, which were probably due to the increase in
SAM observed under the same conditions (Supplementary
Fig. 6g), SAM being a powerful allosteric activator of the trans-
sulfuration pathway46. A general tendency of DZnep to inhibit
the transsulfuration pathway was observed, more pronounced in
cells expressing the mutant MTAN (Supplementary Fig. 7).
Glutathione disulfide (GSSG), generated during enzyme-catalyzed
reduction reactions of GSH with peroxides or disulfide bonds,
tended to decrease under DZnep treatment (Supplementary
Fig. 7). The GSH/GSSH ratio, a measure of oxidative stress, was
not significantly affected by either DZnep or MTAN, indicating
that the mild effects of DZnep and MTAN expression on the
transsulfuration pathway are unlikely to contribute to the circa-
dian period lengthening (Supplementary Fig. 7). These data do
show that WT MTAN also rescues the cells from the mild inhi-
bition of the transsulfuration pathway by DZnep, however.
The somite segmentation clock was strongly affected by inhi-
bition of AHCY, which is in line with the importance of 1 carbon
metabolism for embryonic development. As can be seen in the
Supplementary Movie 3, showing similar results to Supplemen-
tary Movie 2 but merged with brightfield images and displaying
luminescence as a pseudo-color green, period lengthening of the
oscillatory expression of Hes7-luciferase occurred together with a
pronounced delay in the growth of the caudal tip of the pre-
somitic mesoderm as well as in the appearance of new somites,
demonstrating that this molecular clock as well as its output, i.e.
the somitogenesis, were affected by DZnep. The mechanisms
underlying this period lengthening may be distinct from those
involved in the lengthening of the circadian period. Considering
the short period of Hes7 oscillations—2 h—, and the importance
of 3’-UTR-dependent regulation of Hes7 mRNA turnover for its
cyclic expression47, the inhibition of mRNA methylation may at
least in part contribute to the results observed.
We have presented here an identical response to methyl cycle
inhibition on biological oscillators across a wide variety of species.
Only a small number of examples have been reported that
identified aspects of circadian timekeeping shared among
Fig. 5 Rewiring the methyl cycle protects mammalian cells from methylation deficiency. a, bMean luminescence ± SEM of human Bmal1-luc U-2 OS cells
transfected with WT and mutant MTAN, respectively, and treated with different concentrations of DZnep, n= 3 dishes per treatment. c, d Mean
luminescence ± SEM of PER2::LUC MEFs transfected with WT and mutant MTAN, respectively, and treated with different concentrations of DZnep, n= 3
dishes per treatment. e, fMean period ± SEM of Bmal1-luc U-2 OS cells and PER2::LUC MEFs from a, b and c, d, respectively, analyzed by two-way ANOVA
followed by Bonferroni’s test, n= 3 dishes per treatment. The gray bars indicate which comparisons reach significance, all p < 0.0001 (****). g Mean SAH
concentration ± SEM in DZnep-treated PER2::LUC MEFs, n= 3 dishes per treatment, analyzed by Two-Way ANOVA (all sources of variations p < 0.0001)
followed by Bonferroni’s test; all indicated comparisons (a vs. b vs. c) at least p < 0.05. See also Supplementary Fig. 6. h Immunoblots using an antibody
against mono- and di- methylated lysine (K1/2me) reveal that the methylation of some proteins is inhibited by DZnep, and rescued by WT but not D197A
MTAN. The red > signs indicate such proteins. Actin loading control is shown in Supplementary Fig. 6i. i, j Mean mRNA m6A methylation levels ± SEM in
PER2::LUC MEFs transfected with WT or D197A MTAN, then treated with DZnep for 48 h; i, j showing dot blot assay and enzyme-linked immunosorbent
assay-based quantification (ELISA), respectively. Dot blot and ELISA analyzed separately by Two-Way ANOVA (DZnep treatment, MTAN effect and
interactions at least p < 0.05) followed by Bonferroni’s test (*p < 0.05; **p < 0.01), n= 4 dishes. k Dot blot membrane quantified in i, with 150 ng mRNA/
dot, first stained with methylene blue (top) as a loading control.
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rhythmic life, such as oxidation cycles of peroxiredoxin29,48,49
and regulation by oscillating intracellular magnesium con-
centrations50. Building on those early observations, this study
establishes methylation as a universal regulator of rhythmicity.
Importantly, to our knowledge we provide a first potential avenue
of translation of fundamental understanding of methylation
deficiencies to clinical applications. Biopharmaceutics, such as
recombinant MTAN or therapies using genetically engineered
cells expressing MTAN, could be used to treat methylation
deficiencies in the short and longer term. We consider this
superior to approaches directly targeting deficient AHCY in cases
where the deficiency arises from errors of metabolism causing
accumulation of metabolites that are inhibitors of AHCY12; and
even in cases of AHCY polymorphisms, since the endogenous
inactive AHCY in patients would compete with the exogenous
active AHCY.
Methods
Molecular modeling and sequence analyses. 3D protein structures were
obtained from the Protein Data Bank (PDB) for Homo sapiens (PDB 1LI413, S-
adenosylhomocysteine hydrolase complexed with neplanocin, resolution 2.01 Å)
and Mus musculus (PDB 5AXA14, S-adenosylhomocysteine hydrolase with ade-
nosine, chain A, resolution 1.55 Å). All PDB structures underwent preprocessing
including the addition of missing amino acid atoms and hydrogens, removal of
solvent atoms, and hydrogen-bond network optimization and residue protonation
based on predicted pKa values using the Protein Preparation Wizard51 of Maestro
Schrödinger Release 2018-1 [Maestro, Schrödinger, LLC, New York, NY, 2018].
Homology models of Danio rerio (template 1LI4, 100% coverage, 86% sequence
identity), Drosophila melanogaster (template 1LI4, 100% coverage, 81% sequence
identity), Caenorhabditis elegans (template 1LI4, 98% coverage, 77% sequence
identity), Arabidopsis thaliana (template 3OND15 chain A, resolution 1.17 Å, 100%
coverage, sequence 92% identity), Chlamydomonas reinhardtii (template 3OND
chain A, 100% coverage, sequence 80% identity), Ostreococcus tauri (template
3OND chain A, 99% coverage, 79% sequence identity), and Synechococcus elon-
gatus (template 1LI4, 98% coverage, 41% sequence identity) were constructed via
the SWISS-MODEL server52. Model quality was evaluated based on GMQE (global
model quality estimation) ranging from zero to one with high numbers indicating
high model reliability, and QMEAN53, a composite and absolute measure for the
quality of protein models, indicating good or poor agreement between model and
template with values of around 0 or below −4, respectively. GMQE and QMEAN
values for the seven homology models were determined to be 0.98 and 0.85 for D.
rerio, 0.93 and 0.82 for D. melanogaster, 0.87 and 0.35 for C. elegans, 0.99 and 0.31
for A. thaliana, 0.95 and 0.08 for C. reinhardtii, 0.91 and −0.54 for O. tauri, and
0.75 and −0.59 for S. elongatus, respectively. GROMACS version 201854 was uti-
lized for energy minimization of all nine protein structures including oxidized
cofactor NAD+ using force field AMBERff99SB-ILDN55. Cofactor parameters and
topologies were obtained through ACPYPE56 using the AM1-BCC method with
net charge q=−1. The systems including TIP3P water were neutralized with
counter ions (Cl- and Na+) to 0.1 M and minimized via steepest descent with a
maximum force limit of 100 kJ/mol/nm. Molecular docking simulations were
performed using the energy-minimized protein-NAD+ complexes as well as co-
crystallized adenosine (ADN), neplanocin (NOC), and 3-deazaneplanocin A
(DZnep, constructed from co-crystal NOC in 1LI413) using the Lamarckian
Genetic Algorithm provided by the AutoDock4.2 suite57. Protein-ligand interac-
tions were analyzed in LigandScout version 4.258,59.
Multiple sequence alignment of AHCY was performed by CLUSTALW60 with
the multiple sequence viewer from the Maestro module using the following
reference sequences: for human, Genbank: NP_000678.1; mouse, Genbank:
NP_057870.3; zebrafish, Genbank: NP_954688.1; fruit fly, Genbank: NP_511164.2;
C. elegans, Genbank: NP_491955.1; Arabidopsis: NP_193130.1; Chlamydomonas,
Genbank: XP_001693339.1; Ostreococcus, Genbank: XP_022839640.1;
cyanobacteria, Genbank: WP_011243218.1.
For the molecular structure of drugs shown in Fig. 4e, the Open Source web
application MolView was used.
Assay for effect of the inhibition of the methyl cycle on vertebrate circadian
clock. Human U-2 OS cells stably transfected with a Bmal1-luciferase reporter
vector25 and mouse PER2::LUC MEFs24 cell lines were cultivated as previously
described6. Briefly, cells were seeded into 35 mm dishes (Corning, New York, USA)
and allowed to grow to confluence in DMEM/F12 medium (Nacalai, Kyoto, Japan)
containing penicillin/streptomycine/amphotericin (Nacalai). Cells were then
shocked by dexamethasone (Sigma-Aldrich, St. Louis, MO, USA) 200 nM for 2 h,
followed by a medium change including 1 mM luciferine (Nacalai). 35 mm dishes
were then transferred to an 8-dishes luminometer-incubator (Kronos Dio, Atto,
Tokyo, Japan). Photons were counted in bins of 2 min at a frequency of 10 min.
DZnep (SML0305) was purchased from Sigma-Aldrich. Period was estimated by
BioDare261.
For zebrafish cell line and bioluminescence assays, the generation of a per1b-
luciferase cell line from zebrafish PAC2 cells has been previously described62. Cells
were cultured in Leibovitz’s L-15 medium (Gibco, Thermo Fisher Scientific,
Waltham, MA, USA) containing 15% fetal bovine serum (Biochrom AG, Berlin,
Germany), 50 U/mL penicillin/streptomycin (Gibco), and 50 μg/mL gentamicin
(Gibco). Cells were seeded at a density of 50,000-100,000 cells per well in
quadruplicate wells of a 96-well plate in medium supplemented with 0.5 mM beetle
luciferin (Promega, Madison, Wisconsin, USA), and drugs were prepared in water
and added at the concentrations indicated in the figures and legends. Plates were
sealed with clear adhesive TopSeal (Perkin Elmer, Waltham, MA, USA). Since the
circadian clock in these cells is directly light-sensitive and can be entrained by
light-dark cycles, cells were synchronized to a 12:12 LD cycle for 7 days and then
transferred into DD for at least 3 days. Bioluminescence was monitored at 28°C on
a Packard TopCount NXT scintillation counter (Perkin Elmer). DZnep (SML0305)
was purchased from Sigma-Aldrich. Period was estimated by BioDare261.
Assays for the inhibition of DNA, total RNA, mRNA and protein methylation.
Global DNA methylation was quantified by the Abcam 5-methylcytosine assay kit
(ab233486, colorimetric) following manufacturer’s protocol.
Global total RNA and mRNA m6A was quantified by dot blot assay as
described below, and mRNA m6A was further confirmed by the Abcam m6A RNA
Methylation Assay Kit (ab185912, colorimetric) following manufacturer’s protocol.
For the dot blot assay, positively charged nylon membrane was first bathed in
DEPC-treated water for 10 min followed by DEPC-treated 6× SSC buffer for at
least 15 min. During that time, RNA samples were denatured at 95 °C for 3 min
and directly transferred on ice. Membranes were then laid on top of two flat layers
of blotting paper wet but not dripping with 6× DEPC-treated SSC buffer, the
remaining SSC on top of the membrane allowed to seep through it. 3 μl of each
RNA sample (50 ng/μl for mRNA or 400 ng/μl for totRNA) were then spotted on
the membrane and allowed to seep through. RNA was crosslinked to the
membrane in a FUNA-UV crosslinker (Funakoshi, Japan) equipped with 254 nm
UV lights, set to “optimal crosslink” (120,000 microjoules/cm2). Membrane was
rinsed with DEPC-treated water then transferred to 0.02% Methylene Blue in 0.3 M
Na acetate for 15 min in order to confirm the presence and consistent RNA
amount for each dot. After several washes with DEPC-water, membrane was
scanned for record. The membrane was then washed with 0.1%-tTBS (Nacalai
Tesque, Japan) for 10 min, then blocked for 1 h in 5% skimmed milk in 0.1%-tTBS.
The membrane was incubated overnight at 4 °C with the anti-m6A antibody (202
003, Synaptic System, Germany) diluted 1:1000. The next day the membrane was
washed three times 10 min with tTBS then incubated 1 h at RT with the secondary
antibody (NA934, GE Life Science, USA) diluted 1:5000. After three washes of 10
min with tTBS, the membrane was incubated with ECL Prime reagent (GE Life
Science) and imaged with a LAS-4000 imaging system (Fujifilm, Japan).
Protein methylation was measured by standard immunoblotting using the
following antibodies and dilutions: Abcam ab23366, 1:500, for mono- and di-
methylated lysine, Abcam ab5823, 1:500, for histone 4 Arginine 3 symmetric
demethylation, Abcam ab8580, 1:1000, for Histone H3 Lysine 4 trimethylation,
Sigma A5441, 1:10000, for actin, and Abcam ab412 clone 7E6, 1:500, for
monomethylated/dimethylated arginine. The second antibody was GE Life Science
NA934, 1:5000.
Transfection of mammalian cells with expression vectors before luminometry.
The bacterial expression vector pPROEX HTa containing wild-type MTAN8 was
used as a template to amplify a full length MTAN with flanking SalI/NheI
restriction sites at the 5′ and 3′ end, respectively. A single 5′ HA tag 5′-gga-
tacccatacgacgtcccagactacgct-3′ was also facultatively inserted during polymerase
chain reaction (PCR). The SalI/NheI digested, tagged or untagged PCR products
were then ligated into a SalI/NheI-digested pSELECT-HYGRO-MCS (Invivogen,
San Diego, California, USA) using Ligation High V2 (Toyobo, Osaka, japan).
DH5apha E. coli (Takara Bio, Kusatsu, Japan) were transformed with the ligation
products and streaked on a selective plate containing 100 microg/ml hygromycin.
Colonies were screened by Sanger sequencing. The D197A mutation was then
performed, with the wild-type vector as a template, by PCR using the primers 5′-
CCATCTCCGCCGTGGCCGATC3′ and 5′-GATCGGCCACGGCGGAGATGG-3′
containing the mutated GCC codon, together with the 5’ and 3’ primers used for
the cloning of MTAN. D197A MTAN was cloned into pSELECT-HYGRO-MCS as
described above for the wild-type version.
Wild-type or D197A tagged MTAN vectors were transfected into PER2::LUC
MEFs or U-2 OS in 24-well plates at ~90% confluence with Lipofectamine LTX and
PLUS reagent (Invitrogen, Thermo Fisher Scientific) following manufacturer’s
protocol, incubating cells 12–24 (MEFs) or 6–8 (U-2 OS) hours with the
transfection mixes. After transfection, medium was changed, and cells were
incubated for 24–48 hours. Antibiotic/antimycotic was omitted during transfection
and in the first medium change. Expression of the HA-tagged WT and D197A
MTAN was confirmed by immunoblotting using an anti-HA antibody (Roche
11867423001, 1:1000) (Supplementary Fig. 6a and b). For the experiments shown
in Supplementary Fig. 5c–f, transfected confluent cells were trypsinized and plated
and very low density and allowed to grow a few days until ~30% confluence. Cells
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were treated with dexamethasone 200 nM for 2 h for synchronization and, after a
medium change (with 1 mM luciferin and various concentrations of DZnep),
transferred to a luminometer/incubator (CL24A-LIC, Churitsu Electric Corp.,
Nagoya, Japan) set at 35 °C, 5% CO2. Photons were counted in bins of 10 s at a
frequency of 10 min.
Preparation of PER2::LUC cells for SAM and SAH quantification. Cells plated in
10 cm culture dishes at 90% confluence were transfected with wild-type or D197A
MTAN vectors using lipofectamine LTX with PLUS reagent following manu-
facturer’s protocol (Invitrogen). After 12–24 h of incubation with the transfection
mixes, medium was changed once, omitting antibiotic/antimycotic, and cells were
incubated for one day. Cells were then treated with different concentrations of
DZnep and incubated for 48 h. Cells were washed once with 10 ml, then once with
2 ml 5% mannitol (Nacalai). Mannitol was thoroughly removed, and 0.8 ml
methanol was added to the dish, rocking vigorously for 30 s for the methanol to
homogenously cover the cells. Dishes were tipped and 0.55 ml milliQ containing
125 ng/ml BIS-TRIS (Sigma-Aldrich) was added directly to the methanol. Dishes
were once more rocked by hand for 30 s, then the methanol/MilliQ mix (~0.9 ml
due to methanol evaporation) was transferred to a 1.5 ml tube. Two 0.4 ml aliquots
of the extracts were filtered through VIVASPIN 500 3KDa cut-off filters (Sartorius
AG, Göttingen, Germany) then kept at −80 °C until quantification. Dishes con-
taining cells plated simultaneously and submitted to the same treatment were used
to calculate cell counts and total cell volume for normalization.
Preparation of O. tauri and C. reinhardtii for SAM and SAH quantification. O.
tauri or C. reinhardtii were cultivated in their respective culture medium as
described in the corresponding sections on methyl cycle inhibition in these cells.
Cells were then treated with DZnep at the indicated concentration at late log phase.
After 48 h, cells were harvested (~3 × 10E7 C. reinhardtii and ~10E9 O. tauri) by
centrifugation. Cell pellets were then resuspended with 5% mannitol (Naca-
lai) for C. reinhardtii or 1M sorbitol (Sigma-Aldrich) for O. tauri, which was then
thoroughly removed after centrifugation; this wash was performed twice. Cell
pellets were frozen in liquid nitrogen and kept at −80°C before analysis. Cell pellets
were resuspended in 0.4 ml methanol (Nacalai), then 0.275 ml of MilliQ containing
125 ng/ml BIS-TRIS (Sigma-Aldrich) was added to the methanol. Cell resuspen-
sions were submitted to 10 freeze-thaw cycles (liquid nitrogen/4 °C) to break the
cell wall, with full-speed vortexing for 5 s between cycles. After the last thaw,
samples were vortexed at full speed for 10 seconds then centrifuged at 12,000 g at 4
°C for 10 min. Two 0.3 ml aliquots of supernatant were transferred to VIVASPIN
500 3KDa cut-off filters (Sartorius) and centrifuged as recommended by the
manufacturer. Eluates were kept at -80°C until quantification by LC/MS/MS. Total
cell counts (3.01–4.34 × 107) or optical density (0.514–0.646) were used as nor-
malizers for Chlamydomonas or Ostreococcus, respectively.
Hcy, cystathionine, cysteine, GSH, GSSG, SAM and SAH quantification by LC/
MS/MS. The standard stocks of SAM (Cayman Chemical, Ann Arbor, MI, USA)
and SAH (Sigma-Aldrich) were dissolved in water (1 mg/mL) and stored at –30 °C
until use. For the construction of calibration curves, a series of dilutions of SAM
and SAH mixtures were prepared at the concentrations of 0.001, 0.01, 0.05, 0.1, 0.5,
1, 10, 50, 100, and 200 μM.
To quantify the concentrations of SAM and SAH using the multiple reaction
monitoring (MRM), LC/MS/MS conditions were optimized. The LC/MS/MS
quantifications were conducted using a LC-ESI-TQMS (LCMS8030plus, Shimadzu,
Kyoto, Japan). The target product ions were determined as m/z 250.10 for SAM
(CE −15 V), m/z 136.05 for SAH (CE −20 V) from the precursor ions of [M+H]+
(m/z 399 for SAM, m/z 385 for SAH).
The LC conditions were designed as previously described6, with some
modifications: The elution program was set as a linear gradient of 95–10% of
MeCN in water containing 0.1% HCOOH (0–15 min) followed by isocratic 10%
MeCN in water containing 0.1% HCOOH (7min), at a flow rate of 0.2 mL/min.
ZIC-HILIC (2.1 × 150 mm, Merck Millipore, Burlington, MA, USA) was selected as
an analytical column at a temperature of 40 °C.
For the quantification, a dilution series of SAM and SAH mixtures (3 μL
injection) were subjected to MRM quantification as described above. The plotted
peak areas were calculated by LabSolutions 5.9.7 (Shimadzu). The calibration
curves prepared were y= 367,000 (±6019) × for SAM (P-value <0.0001), y=
105,100 (±1395) × for SAH (P-value <0.0001). The SAM and SAH concentrations
of analytes (3 μL injection) were quantified using the calibration curves. All
standards and samples were analyzed in triplicates.
For the quantification of Hcy, cystathionine, cysteine, GSH, and GSSG, the
standards of L-Hcy (Sigma-Aldrich), L-cystathionine (Fujifilm-Wako, Osaka,
Japan), L-cysteine (Tokyo Chemical Industry, Tokyo, Japan), GSH (Fujifilm-
Wako), and GSSG (Fujifilm-Wako) were purchased. For the construction of
calibration curves, a series of dilutions of Hcy, cystathionine, cysteine, GSH, and
GSSG mixtures were prepared just before use at the concentrations of 0.01, 0.1, 1,
10, 50, and 100 μM.
The MRM quantification were conducted by the same platform described
above. The target product ions were determined as m/z 89.90 for Hcy (CE –10 V),
m/z 134.00 for cystathionine (CE –15 V), m/z 59.00 for cysteine (CE –23 V), m/z
178.90 for GSH (CE –14 V), and m/z 355.10 for GSSG (CE –24 V) from the
precursor ions of [M+H]+ (m/z 136 for Hcy, m/z 223 for cystathionine, m/z 122
for cysteine, m/z 308 for GSH, and m/z 613 for GSSG). Since a divalent ion of [M
+ 2 H]2+ of GSSG (m/z 307) was also abundant as well as an ion of [M+H]+
GSSG (m/z 613) at full ion scan mode, the divalent ion was also chosen as
precursor ion to obtain target product ion of m/z 84.10 (CE –26 V).
The calibration curves prepared were y= 17,580 (±153.7) × for Hcy (P-value
<0.0001), y= 6,444 (±50.6) × for cystathionine (P-value <0.0001), y= 2,673
(±33.0) × for cysteine (P-value <0.0001), y= 72,710 (±538.8) × for GSH (P-value
<0.0001), y= 8,206 (±133.0) × for [M+H]+ of GSSG (P-value <0.0001), and y=
14,100 (±211.0) × for [M+ 2 H]2+ of GSSG (P-value <0.0001). The concentrations
of analytes (3 μL injection) were quantified using the calibration curves. All
standards and samples were analyzed in triplicates.
Assay for effect of the inhibition of the methyl cycle on invertebrate circadian
clock. Halteres of two- to seven-day old transgenic ptim-TIM-LUC males63 kept
under 12 h : 12 h light:dark cycles (LD) at 25°C were bilaterally dry dissected. Each
pair was transferred into one well of a 96 well plate (Topcount, Perkin Elmer) filled
with medium containing 80% Schneider’s medium (Sigma-Aldrich), 20% inacti-
vated Fetal Bovine Serum (Capricorn Scientific, Ebsdorfergrund, Germany) and 1%
PenStrep (Sigma-Aldrich). Medium was fortified with 226 µM Luciferin (Biosynth
AG, Staad Switzerland) and supplemented with 10, 100, or 250 µM Dznep A
(Sigma-Aldrich SML0305) diluted in PBS. Plates were sealed with clear adhesive
covers and transferred to a TopCount plate reader (PerkinElmer). Bioluminescence
emanating from each well was measured hourly in LD for two days, followed by
5 days of constant darkness (DD) at 25 °C as previously described64. The ptim-
TIM-LUC reporter contains the timeless (tim) promoter sequences driving
rhythmic expression of the tim cDNA, which is fused to the firefly luciferase cDNA.
Period was estimated by BioDare261.
C. elegans strain N2 (Bristol strain, wild-type was provided by the
Caenorhabditis Genetics Center, University of Minnesota (cbs.umn.edu/cgc/
home). Stocks were maintained on plates with nematode growth medium
(NGM) seeded with HB101 Escherichia coli strain, under 12-h/12-h LD/CW
cycle (400/0 lx and CW (18.5/20 °C, Δ= 1.5 ± 0.125 °C) environmental cycles.
Transgenic animals were generated by microinjection of a Psur-5::luc::gfp
construct at 50 or 100 ng/μL with the pRF4 marker (100 ng/μL)26,65. For
bioluminescence recordings, transgenic Psur-5::luc::gfp nematode populations
were synchronized to the same developmental stage by the chlorine method66.
The harvested eggs were cultured overnight in a 50-mL Erlenmeyer flask with
3.5 mL of M9 buffer, 1× antibiotic-antimycotic (Thermo Fisher Scientific), and
10 µg/mL of tobramycin (Tobrabiotic, Denver Farma S.A., Buenos Aires,
Argentina) at 110 rpm with a Vicking M23 shaker, in LD/CW (400/0 lx; 18.5/20 °
C, Δ= 1.5 °C ± 0.125 °C) conditions. The following day, L1 larvae were
transferred to NGM plates at ZT1 and were grown for 48 h to the L4 stage under
the same LD/CW cycle. Starting at ZT1 (1 h post lights on), the most fluorescent
nematodes were selected manually under a SMZ100 stereomicroscope equipped
with an epi-fluorescence attachment (Nikon, Minato, Tokyo) with a cool Multi-
TK-LED light source (Tolket S.R.L., Buenos Aires, Argentina) to avoid warming
the plate. Picking was performed in a room kept at a constant temperature (18 °
C). L4 larvae were selected after 48 h of light-dark/temperature entrainment and
placed in a luminescence medium containing Leibovitz’s L-15 medium without
phenol red (Thermo Fisher Scientific) supplemented with 1×
antibiotic–antimycotic (Thermo Fisher Scientific), 40 μM of 5-fluoro-2′-
deoxyuridine (FUdR) to avoid new eclosions, 5 mg/mL cholesterol, 10 µg/mL
tobramycin (Denver Farma S.A.), 1 mM D-luciferin (Gold Biotechnology, St
Louis MO, USA), and 0.05% Triton X-100 to increase cuticle permeabilization.
All chemical compounds were purchased from Sigma-Aldrich unless
otherwise specified. Population nematode bioluminescence was recorded in 35-
mm plate dishes (CELLSTAR, Greiner Bio-One, Kremsmünster, Austria)
with 1 mL of the luminescence medium, by means of an AB-2550 Kronos Dio
luminometer (Atto). The signal was integrated for 1 min, and readings were
taken every 10 min.
For single-nematode measurements, Psur-5::luc::gfp nematodes at the L4 stage
were selected as before, washed, and transferred directly to the liquid luminescence
medium. A small, square piece of a transparent 96-well plate containing three ×
three wells was inserted inside a 35-mm dish plate to reduce the total volume and
limit the nematode movement to the center of the plate. One nematode was placed
in the center well with 200 μL of the luminescence medium. Plates were then
transferred to the AB-2550 Kronos Dio luminometer. Single-nematode recordings
were taken every 37 min with an integration time of 4 min.
In both cases, 2 µl of 10 mM DZNep (SML0305 in PBS 1×, pH 7.2) were added
to the luminescence medium (200 µl/well), with a final concentration of 100 µM.
Controls were treated with vehicle (PBS).
As previously described, custom MATLAB scripts (see code availability section
below) were used to analyse the raw luminescence data26. This is necessary because
of the high signal/noise ratio, especially for single worms. Briefly, data were trend-
corrected by dividing by a fixed moving-average window of 24 h, then smoothed
for 12 h. Data were further normalized to the maximum level of luminescence of all
biological replicates along the entire time series on each experiment. After raw data
clean-up by MATLAB, Period was estimated by BioDare261.
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Assay for effect of the inhibition of the methyl cycle on plant and algae
circadian clock. Ostreococcus tauri cells transgenically expressing a translational
fusion of CCA1 to luciferase from the CCA1 promoter (CCA1-LUC)30 were
grown, imaged, and analyzed as described previously49. Briefly, cells were cultured
under 12/12 h blue (Ocean Blue, Lee lighting filter 724) light/dark cycles (17.5 μE/
m2/s) in Keller medium in artificial sea water. Cells were then transferred to 96-well
microplates (Lumitrac, Greiner Bio-one), at a density of ∼15 × 106 cells/ml and
entrained for 7–10 days before recording. One day before recording, 150 μl Keller
medium in artificial sea water was replaced with 150 μl of Keller medium in arti-
ficial sea water containing 333 μM luciferin (Km+). Bioluminescence was mea-
sured on a TopCount (Packard) under constant darkness or constant red+ blue
LED light (5–12 μE/m2).
For protoplast isolation and luminescent imaging, plants expressing luciferase
from the CCA1 promoter in the Col-0 background (kindly provided by Karen
Halliday, University of Edinburgh) were grown in sterile soil under long-day
conditions (16 h light/8 h dark) at 22 °C under 60–70 µmol/m2/s white LED tube
lights (Impact T8). Protoplasts were isolated from 3-week old leaves by
mechanically stripping the lower epidermis from the underlying mesophyll cells
using magic tape, then releasing the mesophyll cells by incubating the remaining
leaf tissue in a solution containing cellulase and pectinase R10 67. Protoplasts in a
solution of 1 mM D-luciferin (Biosynth AG), 5% fetal bovine serum (Sigma-
Aldrich), 50 µg/mL ampicillin, 140 mM NaCl, 115 mM CaCl2, 4.6 mM KCl, 1.86
mM MES pH 5.7 and 4.6 mM glucose were added to white, flat-bottomed 96-well
plates (Lumitrac, Greiner Bio-one) at a concentration of 2 × 105 cells/mL. DZnep
(S7120, Selleck Chemicals LLC, Houston, TX, USA) was added to the protoplasts to
achieve concentrations of 0, 0.125, 0.25, 0.5 or 1 µM from a 1mM stock solution
(prepared in distilled H2O) to a total volume of 200 µL per well. Plates were sealed
with a clear adhesive lid (TopSeal-A, Perkin Elmer). Protoplast luminescence was
read by a LB942 Tristar2 plate reader (Berthold Technologies GmbH & Co. KG,
Bad Wildbad, Germany) every 50 min for 3 s per well, and kept under continuous
red (630 nm) and blue (470 nm) LED light (5 µmol/m2/s each) at 19 °C.
Chlamydomonas reinhardtii strain CBR carrying a codon-adapted luciferase
reporter driven by the tufA promoter in the chloroplast genome68,69 was used.
Culture preparation, bioluminescence monitoring, and data analysis were carried
out as described previously69. Briefly, 5-day-old algal cultures on HS agar medium
were cut out along with the agar by using a glass tube, and transferred to separate
wells of a 96-well microtiter plates. Luciferin (final conc. 200 μM) and various
concentrations of DZnep (Sigma-Aldrich) were added to the wells. Algae were
synchronized by a single cycle of 12-h darkness/12-h light (30 μmol/m2/s) at 17 °C
before bioluminescence monitoring using a custom-made luminometer-
incubator70 in DD at 17 °C. Period was estimated by BioDare261.
Assay for effect of the inhibition of the methyl cycle on prokaryotic circadian
clock. Vibrio harveyi luciferase encoded by luxA and luxB (luxAB) genes was used
as a luminescence reporter in cyanobacterium Synechococcus elongatus PCC 7942.
The cyanobacterial clock-regulated reporter strain kaiBCp::luxAB71 was selected for
the test, expressing luxAB under the control of the promoter of the central clock
genes kaiBC. Synechococcus strains were grown in modified BG11 media72 sup-
plemented with 40 µg/mL of spectinomycin. The cultures grown on BG11 agar
plates for 3 days at 30 °C under continuous cool-white illumination (LL) (50 µE/m2
s) were toothpicked onto fresh BG11 agar plates containing 0.015 g/L of L-
methionine and different concentrations of 3-deazaneplanocin A hydrochloride
(SML0305, Sigma-Aldrich) or sinefungin (Abcam, Cambridge, United Kingdom).
After a single 12 h dark pulse for synchronization, in vivo luminescence rhythms
were captured with a charge-coupled device (CCD) camera set up within a system
to accommodate the agar plates containing the colonies71. Period was estimated by
BioDare261.
Measurement of Hes7 oscillations in the mouse presomitic mesoderm. Pre-
somitic mesoderm (PSM) tissues from three littermate pHes7-UbLuc Tg embryos
were embedded in 0.35% LMP-agarose/culture medium (10% FBS-DMEM/F12), in
a silicon mold mounted onto a φ35mm-glass bottom dish, and luciferin-containing
medium with DZnep (Sigma-Aldrich) or vehicle (MilliQ water) were added.
Time-lapse imaging of PSM was performed with an inverted microscope (IX81,
Olympus, Tokyo, Japan) equipped with an Olympus x10 UPlanApo objective (N.
A.: 0.8) and a VersArray cooled-CCD camera. 16-bit images were acquired every 5
min with Image-Pro Plus (Media Cybernetics, Inc., Rockville, MD, USA), with 2×2
and 4×4 binning and exposures of 100 ms and 4 m 25 s for DIC and
chemiluminescent images, respectively. Raw imaging data were processed and
quantified by ImageJ73. Period was estimated by BioDare261.
Statistics and reproducibility. Statistical analyses were conducted using Graph-
Pad Prism 8 (GraphPad Software Inc., CA, USA). Sample size and the nature of
replicates is specified in the corresponding sections. All experiments have been
reproduced and results confirmed.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying plots shown in main figures are provided in Supplementary
Data 1. All other data shown in this work are available from J.M. Fustin upon reasonable
request.
Code availability
The Matlab code used for C.elegans rhythms analysis is available upon request to
dgolombek@gmail.com or on Zenodo74.
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